Defendant Name: Aeon Global Health Corp.

Defendant Type: Public Company

Document Reference: 34-90003-s

Document Details

Legal Case Name In the Matter of Aeon Global Health Corp.
Document Name SEC Charges Healthcare Company with Standard Internal Control Failures
Document Date 25-Sep-2020
Document Format Administrative Proceeding
File Number 3-20073
Allegation Type Issuer Reporting and Disclosure
Document Summary The SEC stated that: "[It] settled charges against Aeon Global Health Corp., a Georgia-based healthcare company, for failing to maintain internal control over financial reporting (ICFR)."

Disgorgement & Penalty Information

Resolutions
Cease and Desist Order
Compliance Related Independent Consultant

Related Documents:

34-90003 25-Sep-2020 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On September 25, 2020, the SEC instituted settled cease-and-desist proceedings against Aeon Global Health Corp. The Commission stated: "This proceeding involves violations of the federal securities laws in connection with the Respondent’s reporting, books and records, and internal accounting control failures, as well as its failure to maintain Internal Control over Financial Reporting (“ICFR”). Respondent failed to maintain, and did not remediate material weaknesses in, ICFR for fourteen consecutive reporting periods from the period ended March 31, 2016 through the period ended June 30, 2019. In addition, Respondent announced three financial statement restatements during the period from 2016 to 2019."